Literature DB >> 30280251

Did cis- and trans-defensins derive from a common ancestor?

Weiping Zhou1,2, Bin Gao1, Shunyi Zhu3.   

Abstract

Defensins are small, cysteine-rich, cationic antimicrobial peptides, serving as effectors of the innate immune system and modulators of the adaptive immune system. They extensively exist in multicellular organisms and are divided into cis and trans according to their disulfide bridge connectivity patterns. It has been proposed that these two types of defensins convergently originated from different ancestors. Here, we report the discovery of a structural signature involved in the formation of the cysteine-stabilized α-helix/β-sheet (CSαβ) fold of the cis-defensins in some trans-β-defensins, with only one amino acid indel (CXC vs. CC. C, cysteine; X, any amino acid). The indel of the X residue in the structural signature provides a possible explanation as to why cis- and trans-defensins possess different folds and connectivity patterns of disulfide bridges formed in evolution. Although our attempt to convert the structure type of a present-day trans-defensin with the X residue deleted was unsuccessful due to the low solubility of the synthetic peptide, a combination of data from structural signature, function, and phylogenetic distribution suggests that these defensins may have descended from a common ancestor. In this evolutionary scenario, we propose that a progenitor cis-scaffold might gradually evolve into a trans-defensin after deleting the X residue in specific lineages. This proposal adds a new dimension to more deeply studying the evolutionary relationship of defensins with different folds and of other distantly related proteins.

Entities:  

Keywords:  Antimicrobial peptide; Disulfide bridge; Evolution; Fold change; Structural signature

Mesh:

Substances:

Year:  2018        PMID: 30280251     DOI: 10.1007/s00251-018-1086-y

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  53 in total

1.  Antimicrobial peptides of multicellular organisms.

Authors:  Michael Zasloff
Journal:  Nature       Date:  2002-01-24       Impact factor: 49.962

Review 2.  Defensins of vertebrate animals.

Authors:  Robert I Lehrer; Tomas Ganz
Journal:  Curr Opin Immunol       Date:  2002-02       Impact factor: 7.486

Review 3.  Antimicrobial potentials and structural disorder of human and animal defensins.

Authors:  Ehab H Mattar; Hussein A Almehdar; Haitham A Yacoub; Vladimir N Uversky; Elrashdy M Redwan
Journal:  Cytokine Growth Factor Rev       Date:  2015-11-06       Impact factor: 7.638

4.  Sequence diversity and evolution of antimicrobial peptides in invertebrates.

Authors:  Anchalee Tassanakajon; Kunlaya Somboonwiwat; Piti Amparyup
Journal:  Dev Comp Immunol       Date:  2014-06-17       Impact factor: 3.636

5.  Human beta-defensin 3 inhibits cell wall biosynthesis in Staphylococci.

Authors:  Vera Sass; Tanja Schneider; Miriam Wilmes; Christian Körner; Alessandro Tossi; Natalia Novikova; Olga Shamova; Hans-Georg Sahl
Journal:  Infect Immun       Date:  2010-04-12       Impact factor: 3.441

Review 6.  Convergent evolution of defensin sequence, structure and function.

Authors:  Thomas M A Shafee; Fung T Lay; Thanh Kha Phan; Marilyn A Anderson; Mark D Hulett
Journal:  Cell Mol Life Sci       Date:  2016-08-24       Impact factor: 9.261

7.  Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6.

Authors:  D Yang; O Chertov; S N Bykovskaia; Q Chen; M J Buffo; J Shogan; M Anderson; J M Schröder; J M Wang; O M Howard; J J Oppenheim
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

8.  Mutational tipping points for switching protein folds and functions.

Authors:  Yanan He; Yihong Chen; Patrick A Alexander; Philip N Bryan; John Orban
Journal:  Structure       Date:  2012-02-08       Impact factor: 5.006

9.  Conservation of protein structure over four billion years.

Authors:  Alvaro Ingles-Prieto; Beatriz Ibarra-Molero; Asuncion Delgado-Delgado; Raul Perez-Jimenez; Julio M Fernandez; Eric A Gaucher; Jose M Sanchez-Ruiz; Jose A Gavira
Journal:  Structure       Date:  2013-08-08       Impact factor: 5.006

Review 10.  Defensins: antifungal lessons from eukaryotes.

Authors:  Patrícia M Silva; Sónia Gonçalves; Nuno C Santos
Journal:  Front Microbiol       Date:  2014-03-20       Impact factor: 5.640

View more
  5 in total

1.  Adaptively evolved human oral actinomyces-sourced defensins show therapeutic potential.

Authors:  Shunyi Zhu; Bin Gao; Yoshitaka Umetsu; Steve Peigneur; Ping Li; Shinya Ohki; Jan Tytgat
Journal:  EMBO Mol Med       Date:  2021-12-20       Impact factor: 12.137

2.  A Fungal Defensin Inhibiting Bacterial Cell-Wall Biosynthesis with Non-Hemolysis and Serum Stability.

Authors:  Sudong Qi; Bin Gao; Shunyi Zhu
Journal:  J Fungi (Basel)       Date:  2022-02-10

Review 3.  Defensins as a promising class of tick antimicrobial peptides: a scoping review.

Authors:  Jiahui Wu; Xia Zhou; Qiaoqiao Chen; Zhiqiang Chen; Jinyu Zhang; Lele Yang; Yuxuan Sun; Guohui Wang; Jianfeng Dai; Tingting Feng
Journal:  Infect Dis Poverty       Date:  2022-06-20       Impact factor: 10.485

Review 4.  Alarmins and c-Jun N-Terminal Kinase (JNK) Signaling in Neuroinflammation.

Authors:  Nina D Anfinogenova; Mark T Quinn; Igor A Schepetkin; Dmitriy N Atochin
Journal:  Cells       Date:  2020-10-24       Impact factor: 6.600

5.  Evolution-Based Protein Engineering for Antifungal Peptide Improvement.

Authors:  Jing Gu; Noriyoshi Isozumi; Shouli Yuan; Ling Jin; Bin Gao; Shinya Ohki; Shunyi Zhu
Journal:  Mol Biol Evol       Date:  2021-10-27       Impact factor: 16.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.